首页> 美国卫生研究院文献>other >Removal of FKBP12.6 Does Not Alter the Conductance and Activation of the Cardiac Ryanodine Receptor or the Susceptibility to Stress-induced Ventricular Arrhythmias
【2h】

Removal of FKBP12.6 Does Not Alter the Conductance and Activation of the Cardiac Ryanodine Receptor or the Susceptibility to Stress-induced Ventricular Arrhythmias

机译:FKBP12.6的删除不会改变心脏Ryanodine受体的传导和激活也不会改变应激引起的室性心律失常的易感性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The 12.6-kDa FK506-binding protein (FKBP12.6) is considered to be a key regulator of the cardiac ryanodine receptor (RyR2), but its precise role in RyR2 function is complex and controversial. In the present study we investigated the impact of FKBP12.6 removal on the properties of the RyR2 channel and the propensity for spontaneous Ca2+ release and the occurrence of ventricular arrhythmias. Single channel recordings in lipid bilayers showed that FK506 treatment of recombinant RyR2 co-expressed with or without FKBP12.6 or native canine RyR2 did not induce long-lived subconductance states. [3H]Ryanodine binding studies revealed that coexpression with or without FKBP12.6 or treatment with or without FK506 did not alter the sensitivity of RyR2 to activation by Ca2+ or caffeine. Furthermore, single cell Ca2+ imaging analyses demonstrated that HEK293 cells co-expressing RyR2 and FKBP12.6 or expressing RyR2 alone displayed the same propensity for spontaneous Ca2+ release or store overload-induced Ca2+release (SOICR). FK506 increased the amplitude and decreased the frequency of SOICR in HEK293 cells expressing RyR2 with or without FKBP12.6, indicating that the action of FK506 on SOICR is independent of FKBP12.6. As with recombinant RyR2, the conductance and ligand-gating properties of single RyR2 channels from FKBP12.6-null mice were indistinguishable from those of single wild type channels. Moreover, FKBP12.6-null mice did not exhibit enhanced susceptibility to stress-induced ventricular arrhythmias, in contrast to previous reports. Collectively, our results demonstrate that the loss of FKBP12.6 has no significant effect on the conduction and activation of RyR2 or the propensity for spontaneous Ca2+ release and stress-induced ventricular arrhythmias.
机译:12.6-kDa FK506结合蛋白(FKBP12.6)被认为是心脏瑞丹碱受体(RyR2)的关键调节剂,但其在RyR2功能中的确切作用却是复杂且有争议的。在本研究中,我们研究了FKBP12.6的去除对RyR2通道性质以及自发Ca 2 + 释放倾向和室性心律失常发生的影响。脂质双层中的单通道记录显示,在有或没有FKBP12.6或天然犬RyR2的情况下,FK506处理重组RyR2的共表达不会诱导长寿命的亚导状态。 [ 3 H] Ryanodine结合研究表明,在有或没有FKBP12.6的情况下共表达或在有或没有FK506的情况下共表达都不会改变RyR2对Ca 2 + 激活的敏感性。咖啡因。此外,单细胞Ca 2 + 成像分析表明,共表达RyR2和FKBP12.6或仅表达RyR2的HEK293细胞显示出相同的自发Ca 2 + 释放倾向。储存超负荷诱导的Ca 2 + 释放(SOICR)。在有或没有FKBP12.6的情况下,FK506在表达RyR2的HEK293细胞中增加SOICR的幅度,并降低其频率,表明FK506对SOICR的作用独立于FKBP12.6。与重组RyR2一样,来自FKBP12.6-null小鼠的单个RyR2通道的电导率和配体门控特性与单个野生型通道的电导率和配体门控特性没有区别。此外,与以前的报道相反,FKBP12.6-null小鼠对应激诱发的室性心律不齐的敏感性没有增强。总体而言,我们的结果表明,FKBP12.6的丢失对RyR2的传导和激活或自发Ca 2 + 释放的倾向和应激性心律失常没有明显影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号